Enfermedad de Parkinson, información, noticias, tratamientos, fármacos, investigación, terapias.

Science Daily

Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
  1. Parkinson's disease causes one of the highest risks of falling among all neurological conditions. Due to this, many patients develop a fear of falling, even if they've never fallen. Researchers have discovered a way to diagnose subtypes of fear of falling in hopes of improving treatment and quality of life for patients.
  2. The small SynuClean-D molecule interrupts the formation of the alpha-synuclein amyloid fibres responsible for the onset of Parkinson's disease, and reverts the neurodegeneration caused by the disease.
  3. While human genetic mutations are involved in a small number of Parkinson's disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.
  4. Using a new technique known as laser-capture RNA seq, that involves cutting out dopamine neurons from a human brain section with a laser, investigators have cataloged more than 70,000 novel elements active in these brain cells.
  5. Neuroscientists have devised a way to measure dopamine in the brain for up to a year, which they believe will teach them much more about its role in key brain functions and in disorders such as depression and Parkinson's disease.
  6. Researchers have found that ADHD patients had an increased risk of developing Parkinson's and Parkinson-like diseases than individuals with no ADHD history.
  7. Small, New World monkeys called marmosets can mimic the sleep disturbances, changes in circadian rhythm, and cognitive impairment people with Parkinson's disease develop, according to a new study.
  8. Researchers have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson's disease. Their results show that the adverse cognitive effects of deep brain stimulation are linked to a different neural pathway than that responsible for the treatment's desired motor effects. This finding will help optimize treatments for patients with Parkinson's disease.
  9. Researchers have developed a new and improved method to judge the effectiveness of experimental therapies for neurodegeneration--the progressive loss of neurons.
  10. Researchers describe a new set of cell surface markers on dopaminergic progenitor cells, which allow isolation of a more beneficial population of induced neurons for cell replacement therapy. Animals that received transplanted cells that had been selected for the new marker fared better than their counterparts with a typical transplant.

Please publish modules in offcanvas position.